Esophageal cancer other imaging findings: Difference between revisions
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Other imaging studies for esophageal cancer include | Other imaging studies for esophageal cancer include positive emission tomography scanning with 18F-fluorodeoxyglucose (FDG-PET). | ||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
=== | === FDG-PET === | ||
* | * FDG-PET a noninvasive staging modality that is more sensitive than CT or EUS for the detection of distant metastases . | ||
* In 20% of cases, management of esophageal cancer was changed after being scanned with FDG-PET. | |||
* | |||
==References== | ==References== | ||
Revision as of 16:41, 18 December 2017
|
Esophageal cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Esophageal cancer other imaging findings On the Web |
|
American Roentgen Ray Society Images of Esophageal cancer other imaging findings |
|
Risk calculators and risk factors for Esophageal cancer other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
Other imaging studies for esophageal cancer include positive emission tomography scanning with 18F-fluorodeoxyglucose (FDG-PET).
Other Imaging Findings
FDG-PET
- FDG-PET a noninvasive staging modality that is more sensitive than CT or EUS for the detection of distant metastases .
- In 20% of cases, management of esophageal cancer was changed after being scanned with FDG-PET.